Ann Intern Med

1. KAUFFMAN RP
   mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse neonatal outcomes.
   Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621.
   

   >> Share

   
   
2. SWEENEY DA, Kalil AC
   In adults with COVID-19 and severe hypoxemia, lower vs. higher oxygenation targets increased days alive without life support.
   Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00558.
   

   >> Share

   
   

   
   Antiviral Res

3. JI J, Tang T, Zhu M, Wu Z, et al
   Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant.
   Antiviral Res. 2024 Jul 2:105954. doi: 10.1016/j.antiviral.2024.105954.
   

   >> Share

   
   
4. DANIELS A, Padariya M, Fletcher S, Ball K, et al
   Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.
   Antiviral Res. 2024;228:105949.
   

   >> Share

   
   
5. WILLIAMS N, Silva F, Schmolke M
   Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.
   Antiviral Res. 2024 Jun 28:105951. doi: 10.1016/j.antiviral.2024.105951.
   

   >> Share

   
   

   
   BMJ

6. FOX K
   We need a contract between the public and the NHS that focuses on prevention.
   BMJ. 2024;386:q1470.
   

   >> Share

   
   
7. MIR FA
   We need a royal commission to save the struggling NHS.
   BMJ. 2024;386:q1464.
   

   >> Share

   
   
8. WISE J
   Sixty seconds on . . . hologram doctors.
   BMJ. 2024;386:q1456.
   

   >> Share

   
   
9. DOSHI P
   Revolving door: You are free to influence us "behind the scenes," FDA tells staff leaving for industry jobs.
   BMJ. 2024;386:q1418.
   

   >> Share

   
   
10. DYER O
    Mpox: Virus behind new DRC outbreak is most dangerous strain yet, experts warn.
    BMJ. 2024;385:q1454.
    

    >> Share

    
    

    
    Clin Infect Dis

11. JOHNSTON TS, Hage C, Abedon AT, Panda S, et al
    Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Jul 2:ciae279. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Infect Dis

12. DASHTBAN A, Mizani M, Pasea L, Tomlinson C, et al
    Vaccinations, cardiovascular drugs, hospitalisation and mortality in COVID-19 and Long COVID.
    Int J Infect Dis. 2024 Jun 26:107155. doi: 10.1016/j.ijid.2024.107155.
    

    >> Share

    
    
13. TAKASHITA E, Ichikawa M, Fujisaki S, Morita H, et al
    Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients.
    Int J Infect Dis. 2024 Jun 27:107134. doi: 10.1016/j.ijid.2024.107134.
    

    >> Share

    
    
14. GOH YS, Fong SW, Hor PX, Loh CY, et al
    Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1).
    Int J Infect Dis. 2024 Jun 28:107147. doi: 10.1016/j.ijid.2024.107147.
    

    >> Share

    
    
15. KHALIL A, Samara A, Campbell H, Ladhani SN, et al
    Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunisations: we must do better...now.
    Int J Infect Dis. 2024 Jul 1:107148. doi: 10.1016/j.ijid.2024.107148.
    

    >> Share

    
    

    
    J Infect

16. BOOM TT, de Hoog MLA, Westerhof I, Jaddoe V, et al
    Age-specific SARS-CoV-2 transmission differed from human rhinovirus in households during the early COVID-19 pandemic.
    J Infect. 2024 Jun 29:106218. doi: 10.1016/j.jinf.2024.106218.
    

    >> Share

    
    
17. BOYS R, Plank J, Bird P, Fletcher O, et al
    Impact of COVID-19 restrictions on the incidence of respiratory viruses in two British Antarctic Survey bases.
    J Infect. 2024;89:106196.
    

    >> Share

    
    

    
    J Med Virol

18. VOLCIC M, Nchioua R, Pastorio C, Zech F, et al
    Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model.
    J Med Virol. 2024;96:e29783.
    

    >> Share

    
    
19. MEI HE, Schulz AR, Hirseland H, Diekmann LM, et al
    Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination.
    J Med Virol. 2024;96:e29778.
    

    >> Share

    
    
20. KAO CL, Liu PH
    Comment on "A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination".
    J Med Virol. 2024;96:e29785.
    

    >> Share

    
    
21. LOPEZ-AYLLON BD, Marin S, Fernandez MF, Garcia-Garcia T, et al
    Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.
    J Med Virol. 2024;96:e29752.
    

    >> Share

    
    

    
    J Virol

22. RICHARDSON SI, Mzindle N, Motlou T, Manamela NP, et al
    SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcgammaRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    J Virol. 2024 Jul 2:e0067824. doi: 10.1128/jvi.00678.
    

    >> Share

    
    
23. JOHARINIA N, Bonneil E, Grandvaux N, Thibault P, et al
    Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.
    J Virol. 2024 Jul 2:e0085024. doi: 10.1128/jvi.00850.
    

    >> Share

    
    

    
    JAMA

24. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    

    >> Share

    
    

    
    Lancet

25. HIRST JE, Witt A, Mullins E, Womersley K, et al
    Delivering the promise of improved health for women and girls in England.
    Lancet. 2024 Jun 27:S0140-6736(24)01347-3. doi: 10.1016/S0140-6736(24)01347.
    

    >> Share

    
    
26. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    

    >> Share

    
    
27. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    

    >> Share

    
    
28. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    

    >> Share

    
    
29. HO A, Galgut O, Faustini S, Peters N, et al
    Implications of suboptimal measles immunity in UK health-care workers.
    Lancet. 2024 Jun 26:S0140-6736(24)01011-0. doi: 10.1016/S0140-6736(24)01011.
    

    >> Share

    
    
30. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    

    >> Share

    
    

    
    Lancet Infect Dis

31. KAKU Y, Yo MS, Tolentino JE, Uriu K, et al
    Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants.
    Lancet Infect Dis. 2024 Jun 27:S1473-3099(24)00415.
    

    >> Share

    
    

    
    Nature

32. DADONAITE B, Brown J, McMahon TE, Farrell AG, et al
    Spike deep mutational scanning helps predict success of SARS-CoV-2 clades.
    Nature. 2024 Jul 3. doi: 10.1038/s41586-024-07636.
    

    >> Share

    
    
33. BRISBOIS MC, Asani F, Agar J, Rezgui Y, et al
    Give UK science the overhaul it urgently needs.
    Nature. 2024;631:271-274.
    

    >> Share

    
    

    
    Science

34. SHANKER VR, Bruun TUJ, Hie BL, Kim PS, et al
    Unsupervised evolution of protein and antibody complexes with a structure-informed language model.
    Science. 2024;385:46-53.
    

    >> Share

    
    

    
    Travel Med Infect Dis

35. PETAKH P, Tymchyk V, Kamyshnyi O
    Communicable diseases in Ukraine during the period of 2018-2023: Impact of the COVID-19 pandemic and war.
    Travel Med Infect Dis. 2024 Jun 26:102733. doi: 10.1016/j.tmaid.2024.102733.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share